Fagron

Historical price data

Fagron's mission is to optimize and innovate personalized medicine by empowering pharmacists worldwide with a comprehensive technology and supply platform for pharmaceutical compounding. The company has achieved global scale, operating in over 30 countries with ~70 facilities, serving as a critical partner in healthcare for tailored treatments. Its strategy revolves around expanding its proprietary science (excipients, equipment), deepening its educational offerings through Fagron Academy, and leveraging its global supply chain to solidify its market-leading position. Fagron's integrated model addresses a persistent gap in mass-produced pharmaceuticals, creating a stable, high-margin business.

An integrated ecosystem of proprietary excipient bases (e.g., Lollibase®, Pentravan®, SyrSpend®), compounding equipment (FagronLab™), and digital knowledge/education services (Fagron Formulary, Fagron Academy) that enables precise, stable, and effective pharmaceutical compounding.

Fagron competes with large distributors (e.g., McKesson) and regional compounding suppliers, but its differentiated position stems from its integrated platform of patented excipients, equipment, and education. This ecosystem approach creates significant customer lock-in and allows it to compete on value rather than just price.